The inaugural AI Pharma Innovation Summit 2017 (July 25- 27, Boston) is the first industry-specific conference committed to helping large pharma, biotech, leading research institutes and technology pioneers overcome key challenges in the adoption and application of AI technology along the R&D pipeline to optimize drug discovery and development of effective therapies faster and more cost effectively.
Do you want to deliver better medicines faster and more cost effectively?
Are you interested in effectively adopting and strategically applying AI to de-risk drug R&D?
Chaired by Rangaprasad Sarangarajan, SVP & CSO, Berg Health and including speakers from the likes of Numerate, Merck, Genentech, Boehringer Ingelheim and Sanofi, AI Pharma Innovation is a unique meeting that will showcase the real-world application of AI approaches. This event will help you unlock insight and value along the drug discovery and development pipeline to deliver better medicines with better outcomes.
View full event program and speaker line-up here: http://ai-pharma.com/event-guide/
